Play More - Wellness Guide For Dogs
Search
 GO
Play More - Home

Deramaxx®

DER 060037C

Deramaxx is a registered trademark of Novartis AG.

Links

  

 

  

  

 
Adequan® Canine (polysulfated glycosaminoglycan or PSGAG) should not be used in dogs who are hypersensitive to PSGAG or who have a known or suspected bleeding disorder. It should be used with caution in dogs with renal or hepatic impairment. Possible side effects (pain at injection site, vomiting, diarrhea, depression and abnormal bleeding) were mild, transient and self-limiting. Safety studies of PSGAG in breeding, pregnant or lactating dogs have not been conducted. Click here for full product information.

 
* Data on file, Novartis Animal Health US, Inc.

About Deramaxx® (deracoxib)
As with all drugs in this class, side effects involving the digestive system, kidneys or liver may occur. These are normally mild, but may be serious. Pet owners should discontinue therapy and contact their veterinarian immediately if side effects occur. Evaluation for pre-existing conditions and regular monitoring are recommended for pets on any medication, including Deramaxx. Use with other NSAIDs or corticosteroids should be avoided. Click here for full product information.